The drug companies got rich during the pandemic through massive government subsidies. Now, they want to raise the price of lifesaving treatment. Fostering competition could keep costs down.
Pharmaceutical giants are raking in billions selling doses to the richest countries, while Sub-Saharan Africa is struggling to save its people.
Our best articles, in your inbox.
The Washington Monthly is nonprofit and reader-supported. Your tax-deductible gift pays for the reporting you just read.
A new report makes a nuanced case for what post-secondary graduates need to get ahead.
Congress finally opened Pell Grants to short-term job training. Now states have to build the systems that can tell which programs actually work.
High costs, political attacks take a toll as fewer students come, top scholars leave.
New survey data suggests that more Americans might see the value of a degree if schools simplified their pricing systems.
Sign up for the Washington Monthly newsletter to get our stories in your inbox. Opt out any time.
